99-7929. Prodim Denial of Application  

  • [Federal Register Volume 64, Number 62 (Thursday, April 1, 1999)]
    [Notices]
    [Pages 15809-15810]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-7929]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Prodim Denial of Application
    
        On June 5, 1998, the Deputy Assistant Administrator, Office of 
    Diversion Control, Drug Enforcement Administration (DEA) issued an 
    Order to Show Cause to Prodim (Respondent) proposing to deny its 
    application for registration as an exporter of Schedule II, III and IV 
    controlled substances under 21 U.S.C. 958, for reason that its 
    registration would be inconsistent with the public interest pursuant to 
    21 U.S.C. 823 (a) and (b).
        The Order to Show Cause was ultimately received by Randall Tetzner 
    who signed the application for registration on behalf of Respondent. By 
    letter dated September 4, 1998, Respondent waived its opportunity for a 
    hearing and instead submitted a written statement pursuant to 21 CFR 
    1301.43(c).
        Therefore, the Deputy Administrator concludes that Respondent has 
    waived its opportunity for a hearing and hereby enters his final order 
    in this matter based upon the investigative file and Respondent's 
    written statement pursuant to 21 CFR 1301.43 (c) and (e) and 1301.46.
        The Deputy Administrator finds that Randall Tetzner, on behalf of 
    Respondent, submitted an application dated October 7, 1995, for 
    registration with DEA as an exporter of Schedule II, III and IV 
    controlled substances. According to Mr. Tetzner, Respondent wants to be 
    registered in order to send donated or purchased controlled substances 
    to Honduras. In describing Respondent, Mr. Tetzner stated that ``[t]he 
    organization I volunteer with and work with supplies needed medications 
    to rural villages in Honduras. * * * From a base camp in La Paz, a 
    worker brings replacement medications via motorcycle to the villages.''
        After numerous discussions and correspondence between DEA and Mr. 
    Tetzner, an Order to Show Cause was issued on June 5, 1998, proposing 
    to deny Respondent's application for registration. Specifically, the 
    Order to Show Cause alleges that Respondent's registration would be 
    inconsistent with
    
    [[Page 15810]]
    
    the public interest based upon the following:
    
        a. Mr. Tetzner is the sole representative of Prodim. On the 
    application for DEA registration he provided as an address his 
    trailer home. This location does not have secure controlled 
    substance storage facilities and Prodim does not have an alternative 
    location with which to securely store controlled substances, as 
    required by 21 CFR Sec. 1301.72. Therefore, Mr. Tetzner has not 
    demonstrated that he can maintain effective controls against the 
    diversion of controlled substances as required pursuant to 21 U.S.C. 
    Sec. 823(a)(1).
        b. In a letter to DEA dated February 15, 1996, Mr. Tetzner, 
    informed DEA that he had never before exported controlled 
    substances. Therefore, Prodim has no experience in the export of 
    controlled substances. 21 U.S.C. Sec. 958(a) and Sec. 823(a)(5) and 
    (d)(5).
    
        In his written statement dated September 4, 1998, Mr. Tetzner 
    indicated that he never meant to store controlled substances at his 
    home, but instead proposed that Respondent would ``give DEA at least 30 
    days notice of our intent to send the medications, we purchase or 
    recieve [sic] the medications at a hospital or drug company, then while 
    on site we do the required paperwork and on site we ship the 
    medications pursuant [sic] to DEA directives. * * * The medications 
    would only go from an already registered facility, be transferred via 
    paperwork, then the donating agency would then confirm the transfer and 
    they would ship the drugs. In no manner shall PRODIM ever possess these 
    drugs other than to count and verify on site.'' Further, Mr. Tetzner 
    indicated that he has been a paramedic for a number of years and as 
    such understands the importance of documenting the use of controlled 
    substances.
        Pursuant to 21 U.S.C. 958 and 823, the Deputy Administrator may 
    deny an application for registration as an exporter of controlled 
    substances if he finds that such registration would be inconsistent 
    with the public interest. In determining the public interest, the 
    Deputy Administrator shall consider the factors set forth in 21 U.S.C. 
    823(a) for registration to export Schedule II controlled substances and 
    the factors set forth in 21 U.S.C. 823(d) for registration to export 
    Schedule III and IV controlled substances. The factors in these two 
    sections are essentially the same. Pursuant to 21 U.S.C. 823(d), the 
    Deputy Administrator shall consider:
    
    (1) Maintenance of effective controls against diversion of particular 
    controlled substances and any controlled substances in Schedule III, 
    IV, or V compounded therefrom into other than legitimate medical, 
    scientific, or industrial channels;
    (2) Compliance with applicable State and local law;
    (3) Promotion of technical advances in the art of manufacturing these 
    substances and the development of new substances;
    (4) Prior conviction record of applicant under Federal or State laws 
    relating to the manufacture, distribution, or dispensing of such 
    substances;
    (5) Past experience in the manufacture, distribution, and dispensing of 
    controlled substances, and the existence in the establishment of 
    effective controls against diversion; and
    (6) Such other factors as may be relevant to and consistent with the 
    public health and safety.
    
        The Deputy Administrator finds that there is no evidence in the 
    record regarding factors two, three or four. Regarding factor one, 
    there is very little specific evidence in the record as to the controls 
    Respondent will maintain against the diversion of controlled 
    substances. In its written statement, Respondent maintains that it will 
    not take possession of the controlled substances; that the substances 
    would be sent from a location already registered with DEA, that the 
    donating agency would confirm the transfer and ship the rugs, and that 
    Respondent will only count and verify the drugs on site.
        Pursuant to 21 CFR 1301.43(c), a written statement ``shall be made 
    a part of the record and shall be considered in light of the lack of 
    opportunity for cross-examination in determining the weight to be 
    attached to matters of fact asserted therein.'' The Deputy 
    Administrator finds that the assertions in Respondent's written 
    statement warrant little weight. The Deputy Administrator is unable to 
    determine from Respondent's written statement who would be responsible 
    for the controlled substances since the controlled substances would be 
    stored at the donating agency and the donating agency would confirm the 
    transfer and ship the drugs. Further, the Deputy Administrator is 
    unable to determine what controls against diversion would be in place 
    during the shipment of any controlled substances. Of even greater 
    concern is that the Deputy Administrator is unable to determine from 
    Respondent's written statement the identity or location of the donating 
    agency or agencies, and is therefore unable to determine whether 
    effective controls are maintained to prevent the diversion of exported 
    controlled substances.
        Regarding factor five while Mr. Tetzner indicates that he has 
    handled controlled substances as a paramedic and a Navy corpsman, there 
    is no evidence that he has any experience in exporting controlled 
    substances, nor in the responsibilities of a DEA registrant in 
    preventing the diversion of controlled substances.
        As to factor six, the record indicates that Respondent and Mr. 
    Tetzner do not have sufficient knowledge and understanding of the 
    export requirements set forth in 21 U.S.C. 953 and 21 CFR 1312.21. In 
    Respondent's written statement, Mr. Tetzner states that it will ``give 
    the DEA at least 30 days notice of our intent to send the medications. 
    * * *'' Respondent does not discuss whether its proposed exportations 
    would meet the requirements of 21 U.S.C. 953, nor does it indicate that 
    it will follow the procedures set forth in 21 CFR 1312.21 regarding 
    obtaining the authorization to export specific shipments. Particularly 
    troubling to the Deputy Administrator is that the record indicates that 
    Mr. Tetzer was advised by DEA on several occasions of these 
    requirements and was told where he could obtain a copy of the 
    regulations, yet he did not do so.
        The Deputy Administrator concludes that based upon the record 
    currently before him Respondent's registration as an exporter of 
    controlled substances would be inconsistent with the public interest. 
    There is no evidence that Respondent would maintain effective controls 
    against the diversion of controlled substances; that Respondent 
    possesses relevant experience in the handling of controlled substances; 
    and that Respondent understands the export requirements set forth in 21 
    U.S.C. 953 and 21 CFR 1312.21.
        Accordingly, the Deputy Administrator of the Drug Enforcement 
    Administration pursuant to the authority vested in him by 21 U.S.C. 823 
    and 958 and 28 CFR 0.100(b) and 0.104, hereby orders that the 
    application for registration submitted by Prodim, be, and it hereby is, 
    denied. This order is effective May 3, 1999.
    
        Dated: March 15, 1999.
    Donnie R. Marshall,
    Deputy Administrator.
    [FR Doc. 99-7929 Filed 3-31-99; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
04/01/1999
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
99-7929
Pages:
15809-15810 (2 pages)
PDF File:
99-7929.pdf